p16INK4 is inactivated by extensive CpG methylation in human hepatocellular carcinoma

被引：197

作者：

Matsuda, Y ^{[1
]}

Ichida, T ^{[1
]}

Matsuzawa, J ^{[1
]}

Sugimura, K ^{[1
]}

Asakura, H ^{[1
]}

机构：

[1] Univ Nigeria, Sch Med, Dept Internal Med 3, Niigata 9518122, Japan

来源：

GASTROENTEROLOGY | 1999年 / 116卷 / 02期

关键词：

D O I：

10.1016/S0016-5085(99)70137-X

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Background & Aims: The molecular status of the p16(INK4) tumor-suppressor gene has not been fully elucidated in hepatocellular carcinoma. The aim of this study was to clarify the mechanism that gives rise to inactivation of p16(INK4) in hepatocellular carcinoma. Methods: The status of p16(INK4) was evaluated in 60 hepatocellular carcinomas by immunohistochemical staining, differential polymerase chain reaction, single-strand conformational polymorphism, methylation-specific polymerase chain reaction, and methylation-sensitive single nucleotide primer extension. Results: Immunohistochemical staining showed that 29 of the 60 tumors exhibited complete toss of p16(INK4) expression. High levels of DNA methylation were detected in 24 of 29 cases of hepatocellular carcinoma with negative p16(INK4) expression, with methylation of 60%-85% of the CpG islands. In contrast, the level of methylation was <25% in tumors with faint p16(INK4) staining and no methylation was detected in tumors with positive immunostaining. Intragenic alteration of p16(INK4) was detected in 4 cases. Conclusions: A strong correlation was found between the extent of methylation and the degree of expression of p16(INK4) in tumor tissues, indicating that epigenetic change due to extensive CpG methylation is the main cause of inactivation of p16(INK4) in hepatocellular carcinoma.

引用

页码：394 / 400

页数：7

共 27 条

[1] Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population [J].

Biden, K ;

Young, J ;

Buttenshaw, R ;

Searle, J ;

Cooksley, G ;

Xu, DB ;

Leggett, B .

HEPATOLOGY, 1997, 25 (03) :593-597

[2]

BOBBA A, 1995, PCR METH APPL, V4, P309

[3]

Bonilla F, 1998, INT J ONCOL, V12, P583

[4] RATES OF P16(MTS1) MUTATIONS IN PRIMARY TUMORS WITH 9P LOSS [J].

CAIRNS, P ;

MAO, L ;

MERLO, A ;

LEE, DJ ;

SCHWAB, D ;

EBY, Y ;

TOKINO, K ;

VANDERRIET, P ;

BLAUGRUND, JE ;

SIDRANSKY, D .

SCIENCE, 1994, 265 (5170) :415-416

[5] Germ-line mutations of the p16(INK4)(MTS1) gene occur in a subset of patients with hepatocellular carcinoma [J].

Chaubert, P ;

Gayer, R ;

Zimmermann, A ;

Fontolliet, C ;

Stamm, B ;

Bosman, F ;

Shaw, P .

HEPATOLOGY, 1997, 25 (06) :1376-1381

[6]

GERADTS J, 1995, CANCER RES, V55, P6006

[7]

GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531

[8]

Gonzalgo ML, 1997, CANCER RES, V57, P5336

[9] Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE) [J].

Gonzalgo, ML ;

Jones, PA .

NUCLEIC ACIDS RESEARCH, 1997, 25 (12) :2529-2531

[10] Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands [J].

Herman, JG ;

Graff, JR ;

Myohanen, S ;

Nelkin, BD ;

Baylin, SB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9821-9826

← 1 2 3 →